Abstract
The aim of this study was to assess the outcome of patients with aplastic anemia (AA), receiving rabbit anti-thymocyte globulin (Thymoglobulin, SANOFI) and cyclosporin, as first line treatment. Eligible were 955 patients with AA, treated first line with Thymoglobulin, between 2001 and 2008 (n = 492), or between 2009 and 2012 (n = 463). The median age of the patients was 21 years (range 1-84). Mortality within 90 days was 5.7% and 2.4%, respectively in the two time periods (P = .007).The actuarial 10-year survival for the entire population was 70%; transplant free survival was 64%. Predictors of survival in multivariate analysis, were severity of the disease, patients age and the interval between diagnosis and treatment. Survival was 87% vs 61% for responders at 6 months versus nonresponders (P < .0001). The 10-year survival of nonresponders at 6 months, undergoing a subsequent transplant (n = 110), was 64%, vs 60% for patient not transplantated (n = 266) (P = .1). The cumulative incidence of response was 37%, 52%, 65% respectively, at 90, 180, and 365 days. In multivariate analysis, negative predictors of response at 6 months, were older age, longer interval diagnosis treatment, and greater severity of the disease. In conclusio...Continue Reading
References
Dec 3, 1999·British Journal of Haematology·E Di BonaV De Rossi
Jan 19, 2007·Haematologica·Anna LocasciulliUNKNOWN Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplant Group
Jan 15, 2011·Blood·André TichelliJakob R Passweg
Jun 29, 2011·Pediatric Hematology and Oncology·Rebecca J DeyellKirk R Schultz
Aug 5, 2011·The New England Journal of Medicine·Phillip ScheinbergNeal S Young
Mar 10, 2012·Journal of Cancer Research and Clinical Oncology·Chun ChenShao-Liang Huang
Apr 21, 2012·Blood·Phillip Scheinberg, Neal S Young
May 1, 2012·Blood·Judith C MarshUNKNOWN European Blood and Marrow Transplant Group Severe Aplastic Anaemia Working Party
Nov 21, 2012·Bone Marrow Transplantation·M AljurfJ R Passweg
Nov 12, 2013·Haematologica·Dae Chul JeongSeiji Kojima
Feb 13, 2015·Annals of Hematology·Carlos VallejoUNKNOWN Bone Marrow Failure Spanish Study Group (Pethema-GETH)
Nov 17, 2015·British Journal of Haematology·Sally B KillickUNKNOWN British Society for Standards in Haematology
Jun 25, 2016·International Journal of Hematology·Takahiro SuzukiYoshinobu Kanda
Jul 5, 2016·International Journal of Hematology·Suporn ChuncharuneeSurapol Issaragrisil
Jan 13, 2017·International Journal of Hematology·Jin HayakawaYoshinobu Kanda
Apr 20, 2017·The New England Journal of Medicine·Danielle M TownsleyNeal S Young
Aug 18, 2017·Annals of Hematology·Elias H AttaPhillip Scheinberg
Oct 2, 2017·Annals of Hematology·Nan YangWanggang Zhang
Citations
Jun 18, 2019·British Journal of Haematology·Atsushi NaritaUNKNOWN Aplastic Anaemia Working Party of the Asia-Pacific Blood, Marrow Transplantation Group
Jan 11, 2019·International Journal of Hematology·Nana SasakiUNKNOWN Kyoto Clinical Hematology Study Group (KOTOSG) investigators
Dec 4, 2019·Hematology·Changjuan GuXiaotian Xie
Jul 1, 2020·Annals of Hematology·Jiali HuoYizhou Zheng
Nov 14, 2019·The Indian Journal of Medical Research·Salahuddin SiddiquiReinhold Munker
Oct 10, 2020·Annals of Hematology·Yang LanXiaofan Zhu
Sep 25, 2020·Journal of Pediatric Hematology/oncology·Fuxing LiXiaotian Xie
Mar 30, 2021·Deutsche medizinische Wochenschrift·Jens Panse
May 13, 2021·Medicina clínica·Juan Carlos Vallejo Llamas
Jun 29, 2021·Medicina Clínica·Juan Carlos Vallejo Llamas
Jul 23, 2021·International Journal of General Medicine·Meng-Xue ZhangXiao-Qin Wang
Jul 17, 2021·Annals of Hematology·Lalita NorasetthadaUNKNOWN Thai Aplastic Anemia Study Group
Aug 4, 2021·American Journal of Hematology·Kristin A ShimanoJessica Boklan
Sep 2, 2021·Revista da Associação Médica Brasileira·Peiyuan DongYizhou Zheng